Dainippon Pharmaceutical Company Limited Company Profile

17:37 EST 24th November 2014 | BioPortfolio

Antibiotics Diagnostics Veterinary

Location

6-8 Dosho-machi 2-chome Chuo-ku
Osaka
Osaka
541
Japan

Contact

Phone: 81 6 6203 5321
Fax: 81 6 203 6581


News Articles [23 Associated News Articles listed on BioPortfolio]

Dainippon Sumitomo And Others To Invest JPY 845 Million In Japan Vaccine Company

Dainippon Sumitomo, Japan BCG, and INCJ will invest a total of JPY 845 million ($10 million) into the vaccine development company, Create Vaccine, established in 2013 by Dainippon Sumitomo and Japan ...

Sumitomo Dainippon, SanBio partner over SB623 cell therapy for chronic stroke

Sumitomo Dainippon Pharma has entered into a joint development and license agreement with SanBio for exclusive marketing rights in the US and Canada for SB623, a cell therapy to treat patients with ch...

Dainippon Sumitomo and Daiichi Sankyo cooperate on lurasidone in South America

Japanese drug majors Dainippon Sumitomo Pharma and Daiichi Sankyo have entered into a license agreement for the commercialization of lurasidone, an atypical antipsychotic agent discovered by DSP, in B...

Dainippon Sumitomo’s BBI608 Colorectal Cancer Phase III Trials Halted

Dainippon Sumitomo has discontinued its colorectal cancer Phase III trials with anticancer drug BBI608, the company announced on May 23.

Dainippon Sumitomo discontinues Phase III BBI608 trial

Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506) discontinued the Phase III CO.23 trial of BBI608 plus best supportive care (BSC) to treat colorectal cancer after it failed an interim futility analysis...

Sumitomo Dainippon management update

GlaxoSmithKline, Dainippon Sumitomo deal

Dnavec, Sumitomo Dainippon deal

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Dainippon Sumitomo Pharma Co., Ltd.

Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP's strong...

Dainippon Sumitomo Pharma America, Inc.

Dainippon Sumitomo Pharma America, Inc. (DSPA) located in Fort Lee, N.J., is a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP). On April 1, 2010, DSP's two North American operations - DSPA and...

Dainippon Pharmaceutical Company Limited

Antibiotics Diagnostics Veterinary

Chelsea Therapeutics International, Ltd.

Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires, develops and commercializes innovative products for the treatment of a variety of huma...

Sepracor Inc.

Sepracor Inc., an indirect, wholly-owned subsidiary of Dainippon Sumitomo Pharma Co., Ltd., is a research-based pharmaceutical company dedicated to treating and preventing human d...

More Information about "Dainippon Pharmaceutical Company Limited" on BioPortfolio

We have published hundreds of Dainippon Pharmaceutical Company Limited news stories on BioPortfolio along with dozens of Dainippon Pharmaceutical Company Limited Clinical Trials and PubMed Articles about Dainippon Pharmaceutical Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dainippon Pharmaceutical Company Limited Companies in our database. You can also find out about relevant Dainippon Pharmaceutical Company Limited Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record